HCID 89739155, compound → HCID 71678378, compound
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[CH:19]=[CH:18][C:17]([C:20]3[O:24][C:23]([C:25]4[CH:33]=[CH:32][C:31]([C:34]([F:37])([F:36])[F:35])=[C:30]5[C:26]=4[CH:27]=[CH:28][NH:29]5)=[N:22][C:21]=3[C:38](=[O:40])[NH2:39])=[CH:16][CH:15]=2)[CH2:10][C:9]1([CH3:42])[CH3:41])=O)(C)(C)C>C(Cl)Cl.C(O)(C(F)(F)F)=O>[F:36][C:34]([F:35])([F:37])[C:31]1[CH:32]=[CH:33][C:25]([C:23]2[O:24][C:20]([C:17]3[CH:16]=[CH:15][C:14]([N:11]4[CH2:12][CH2:13][NH:8][C:9]([CH3:41])([CH3:42])[CH2:10]4)=[CH:19][CH:18]=3)=[C:21]([C:38]([NH2:39])=[O:40])[N:22]=2)=[C:26]2[C:30]=1[NH:29][CH:28]=[CH:27]2Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
4-{4-[4-Carbamoyl-2-(7-trifluoromethyl-1H-indol-4-yl)-oxazol-5-yl]-phenyl}-2,2-dimethyl-piperazine-1-carboxylic acid tert-butyl ester (0.18 g crude) was dissolved in a mixture of DCM and TFA (30 mL 2:1), and the solution was stirred at RT for 2 hrs, when the solvent was removed in vacuo. The residue was partitioned between water and EtOAc. The organic phase was dried over Na2SO4 and the solvent was removed in vacuo to give the crude product which was purified by prep-HPLC to give the title compound (60 mg, 41% from ethyl 5-(4-(4-(tert-butoxycarbonyl)-3,3-dimethylpiperazin-1-yl)phenyl)-2-iodooxazole-4-carboxylate).
Workup
- customwhen the solvent was removed in vacuo
- customThe residue was partitioned between water and EtOAc
- dry with materialThe organic phase was dried over Na2SO4
- customthe solvent was removed in vacuo
- customto give the crude product which
- customwas purified by prep-HPLC
Sources & evidence
- ORD record
- ord-b6a97485779b4e6481627fad5c9b310b
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09133180B2
Reaction notes
Loading…